CLINICAL_TRIALS
trial_result
· 2016-01-26
Clinical Trial Update: An Observational Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer (AXIOM)
Summary
An observational study of capecitabine (Xeloda) in metastatic colorectal cancer (AXIOM) has completed with results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Colorectal Cancer | Status: COMPLETED | Results posted: 2016-01-26